Absence of aprataxin gene mutations in a Greek cohort with sporadic early onset ataxia and normal GAA triplets in frataxin gene
AuthorDaiou, C.; Christodoulou, K.; Xiromerisiou, G.; Panas, M.; Dardiotis, E.; Kladi, A.; Speletas, M.; Ntaios, G.; Papadimitriou, A.; Germenis, A.; Hadjigeorgiou, G. M.
Phenotype of patients with the aprataxin gene mutation varies and according to previous studies, screening of aprataxin gene could be useful, once frataxin gene mutation is excluded in patients with normal GAA expansion in frataxin gene. In the present study, we sought to determine possible causative mutations in aprataxin gene (all exons and flanking intronic sequences) in 14 Greek patients with sporadic cerebellar ataxia all but one without GAA expansion in frataxin gene (1 patient was heterozygous). No detectable point mutation or deletion was found in the aprataxin gene of all the patients. Our results do not confirm the previous studies. This difference may be attributed to the different populations studied and possible different genetic background. It is still questionable whether the screening for aprataxin mutation in Greek patients' Friedreich ataxia phenotype is of clinical importance; larger, multicenter studies are necessary to clarify this issue.
Showing items related by title, author, creator and subject.
Crocins, the active constituents of Crocus Sativus L., counteracted ketamine-induced behavioural deficits in rats Georgiadou, G.; Grivas, V.; Tarantilis, P. A.; Pitsikas, N. (2014)Experimental evidence indicates that the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist ketamine impairs cognition and can mimic certain aspects of positive and negative symptoms of schizophrenia in rodents. ...
Impact of pregabalin treatment on pain, pain-related sleep interference and general well-being in patients with neuropathic pain: A non-interventional, multicentre, post-marketing study Anastassiou, E.; Iatrou, C. A.; Vlaikidis, N.; Vafiadou, M.; Stamatiou, G.; Plesia, E.; Lyras, L.; Vadalouca, A. (2011)Background and Objectives: Numerous controlled clinical trials have demonstrated the safety and efficacy of pregabalin in the treatment of neuropathic pain. The objectives of the present study were to assess the impact of ...
Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801 Pitsikas, N.; Zisopoulou, S.; Sakellaridis, N. (2006)There is experimental evidence indicating that the noncompetitive NMDA receptor antagonist MK-801 impairs cognition and produces a series of schizophrenia-like symptoms in rodents (hypermotility, stereotypies, and ataxia). ...